FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Article
Vallejo, Adrián, Erice, Oihane, Entrialgo-Cadierno, Rodrigo
, Feliu, Iker, Guruceaga, Elizabeth
, Perugorria, Maria J., Olaizola, Paula, Muggli, Alexandra, Macaya, Irati, O’Dell, Michael, Ruiz-Fernandez de Cordoba, Borja, Ortiz-Espinosa, Sergio, Hezel, Aram F., Arozarena, Imanol, Lecanda, Fernando, Avila, Matias A.
, Fernandez-Barrena, Maite G., Evert, Matthias, Ponz-Sarvise, Mariano
, Calvisi, Diego F., Banales, Jesus M. and Vicent, Silve
(2021)
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.
Journal of Hepatology 75 (2), pp. 363-376.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Hepatology | ||||
| Publisher | Elsevier | ||||
| Place of Publication | AMSTERDAM | ||||
| Volume | 75 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | pp. 363-376 | ||||
| Date | 2021 | ||||
| Date of publication | 29 Feb 2024 12:35 | ||||
| Institutions | Medicine > Lehrstuhl für Pathologie | ||||
| Identification Number |
| ||||
| Keywords | MEVALONATE PATHWAY; INHIBITION; KINASE; GROWTH; IDENTIFICATION; ACTIVATION; PROGNOSIS; REVEALS; FUSIONS; DEFINE; FOSL1; cholangiocarcinoma; transcription factors; genetics; targeted therapies | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56645 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric